MNC Kapital Indonesia Tbk vs Ikapharmindo Putramas Tbk. — how do they compare? MNC Kapital Indonesia Tbk trades at Rp50 (market cap 2.13T, 136K 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp181 (market cap 303.24B, 22.5K 24h volume). The key difference: MNC Kapital Indonesia Tbk is far larger — about 7× Ikapharmindo Putramas Tbk.'s market cap, and MNC Kapital Indonesia Tbk is more actively traded (136K versus 22.5K). Which is the better fit depends on your goals.
| BCAP | IKPM | |
|---|---|---|
Market Cap | 2.13T | 303.24B |
Volume | 136K | 22.5K |
Lot | 1.36K | 225 |
Turnover | 6.8M | 4.12M |
Average Price | 50 | 182.95 |
Value | 6.8M | 4.12M |
Indicative Equilibrium Price | 50 | 188 |
Indicative Equilibrium Volume | 1 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT MNC Kapital Indonesia Tbk formerly PT Bhakti Capital Indonesia Tbk was established on 15 July 1999, resulting from the restructuring and consolidation of PT Bhakti Investama Tbk, its holding company. At the time it was established, the Company commenced its business activities in the securities sector, among others are financial advisory, brokerage, underwriting, and research and development. In 2003, the Company carried out a business consolidation and transformed into a holding company of several subsidiaries that are engaged in financial services sector, namely PT Bhakti Finance, PT Bhakti Securities, and PT Bhakti Asset Management.
Read more on BCAP →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →